Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

24,279 signal articles · 44 in last 24h · 115,444 total before filter · latest 54m ago
44last 24h
1769last 7d
297● bullish (7d)
170● bearish (7d)
205publishers
AllMacro316Earnings818M&A103Regulatory25Product16Analyst26
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Nvidia (NVDA) Bets on Design Tools While AMD (AMD) Scales the Hardware Stack
Insider Monkey9d agoneutral
Nvidia (NVDA) Bets on Design Tools While AMD (AMD) Scales the Hardware Stack

Nvidia Corporation (NASDAQ:NVDA) already sells the chips that train and run the world’s AI models. On July 26, the company made a case for owning a lot more of the design process too, expanding NVIDIA Agent Toolkit for engineering with the PhysicsNeMo and CUDA-X libraries that let software agents run physics simulations, solvers, and even […]

DoorDash (DASH) Could Be 16% Below Fair Value On Q2 Results And Drone Approval
Simply Wall St.9d agoneutral
DoorDash (DASH) Could Be 16% Below Fair Value On Q2 Results And Drone Approval

DoorDash (DASH) has put fresh numbers on the table after reporting second quarter results that combined higher sales, softer net income, a completed share buyback tranche, and a key FAA certification for its DoorDash Air drone program. See our latest analysis for DoorDash. DoorDash shares have picked up speed in recent weeks, with a 7 day share price return of 7.1% and a 90 day share price return of 21.0%, even though the year to date share price return is still down 5.7%. Over a longer...

Is Axon Enterprise (AXON) Fairly Valued As Raised 2026 Guidance Meets Margin Pressure?
Simply Wall St.9d agoneutral
Is Axon Enterprise (AXON) Fairly Valued As Raised 2026 Guidance Meets Margin Pressure?

Axon Enterprise (AXON) lifted its 2026 revenue growth outlook to a range of 32% to 34% after reporting Q2 results that exceeded sales estimates but came with margin pressure and an earnings per share miss versus expectations. See our latest analysis for Axon Enterprise. The raised 2026 guidance comes after a sharp rebound in Axon Enterprise’s share price, with a 7 day share price return of 14.74% and a 90 day share price return of 42.77%. That pace contrasts with a 1 year total shareholder...

Symbotic (SYM) Is Up 15.3% After Q3 Profit Return And Higher Revenue Outlook - What’s Changed
Simply Wall St.9d agoneutral
Symbotic (SYM) Is Up 15.3% After Q3 Profit Return And Higher Revenue Outlook - What’s Changed

Symbotic Inc. recently reported third-quarter 2026 results, with revenue rising to US$720.84 million and net income reaching US$11.67 million, alongside the appointment of former Bain Capital Co‑Chair Steve Pagliuca to its Board and new fourth‑quarter revenue guidance of US$760 million to US$780 million. The company’s return to profitability over both the quarter and the nine‑month period, coupled with revenue guidance that points to continued operational momentum, could be especially...

MACOM Technology Solutions Q3 Earnings Call Highlights
MarketBeat9d agoneutral
MACOM Technology Solutions Q3 Earnings Call Highlights

MACOM Technology Solutions (NASDAQ:MTSI) reported record fiscal third-quarter results, citing strong demand across its data center, industrial and defense, and telecom markets. The company also issued fourth-quarter guidance that calls for another sequential increase in revenue, margins and adjusted

Lexicon Pharmaceuticals Q2 Earnings Call Highlights
MarketBeat9d agoneutral
Lexicon Pharmaceuticals Q2 Earnings Call Highlights

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported a wider second-quarter loss as revenue declined sharply from the prior-year period, while the company highlighted completed enrollment in its Phase III SONATA-HCM trial and outlined plans to resubmit a new drug application for ZYNQUISTA in type 1 diabet

MKS Q2 Earnings Call Highlights
MarketBeat9d agoneutral
MKS Q2 Earnings Call Highlights

MKS (NASDAQ:MKSI) reported second-quarter 2026 revenue of $1.25 billion, up 16% sequentially and 28% from a year earlier, as demand increased across semiconductor, electronics and packaging, and specialty industrial markets. Management said revenue and key profitability measures reached the high end

Lightbridge Q2 Earnings Call Highlights
MarketBeat9d agoneutral
Lightbridge Q2 Earnings Call Highlights

Lightbridge (NASDAQ:LTBR) reported progress in its nuclear fuel development program during the second quarter and first half of 2026, including the removal of its first irradiated fuel material samples from Idaho National Laboratory’s Advanced Test Reactor and steps toward commercial-scale fabricati

Ligand Pharmaceuticals Q2 Earnings Call Highlights
MarketBeat9d agoneutral
Ligand Pharmaceuticals Q2 Earnings Call Highlights

Ligand Pharmaceuticals (NASDAQ:LGND) reported second-quarter 2026 results marked by higher royalty revenue and adjusted earnings, while highlighting the post-quarter close of its XOMA Royalty acquisition and a $700 million zero-coupon convertible-note offering. Total revenue rose 34% year over year